Equibles does not estimate personal net worth.
Get an email with a short summary when Mirum Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get MIRM alertsChristopher Peetz is recorded as CEO at Mirum Pharmaceuticals, Inc. (MIRM). The newest filing on record that lists Christopher Peetz as CEO at Mirum Pharmaceuticals, Inc. (MIRM) is dated April 23, 2024. The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $10,441,224 for Christopher Peetz in fiscal 2025, including a base salary of $755,000. Disclosed compensation is on record for 8 fiscal years. Christopher Peetz has spoken on 3 earnings calls across 1 company, most recently for Mirum Pharmaceuticals, Inc. on May 8, 2024. Mirum Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mirum Pharmaceuticals, Inc. includes Michael Grey (CEO), Eric Bjerkholt (CFO), Peter Radovich (COO) and 5 others.
“2024 is tracking to be another year of significant growth for us. And I'm very pleased to highlight our progress across key strategic objectives to grow the commercial business, expand the indications of our commercial medicines and advance volixibat to market.”
“In terms of communication at the point of interim for the VISTA study, assuming a positive interim, we would communicate that the interim has occurred and study continues as planned, which would be the extent of the information that we received here on the team as well.”
“This was another strong quarter of execution at Mirum. The team has continued to grow our business by focusing on delivering life-changing medicines for patients and their families living with rare diseases.”
Start not stated–present
Last confirmed April 23, 2024
Start not stated–2024-04-23
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $755,000 | $10,441,224 |
| 2024 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $730,000 | $6,598,551 |
| 2023 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $660,000 | $6,451,720 |
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $624,000 | $4,402,664 |
| 2021 | Mirum Pharmaceuticals, Inc. (MIRM) | President and Chief Executive Officer | $600,000 | $4,130,831 |
| 2020 | Mirum Pharmaceuticals, Inc. (MIRM) | President and Chief Executive Officer | $511,818 | $3,003,978 |
| 2019 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer and President | $457,614 | $6,235,185 |
| 2018 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer and President | $32,083 | $32,083 |
